Centauri Therapeutics receives an additional $5.1M from CARB-X to progress ABX-01 lead compound to first in human clinical trials CARB-X provides an additional $5.1M to complete the non-clinical ...

Materials innovation company, Xampla, announces a major commercial advance as Bunzl UK & Ireland add Huhtamaki’s ‘Taste’ hot ...

The progression to a Phase IIb clinical study follows encouraging results from Exonate’s Phase Ib/IIa study in March 2024 1.

Nurturing leads and customers isn’t just about courtesy- it’s a powerful way to boost engagement, conversions, and long-term ...

Our public safety connectivity solutions support the frequency bands most commonly used by public safety, emergency services ...

The Cambridge Index fell 510.5 points or 2.0% to close at 25,435.5, as seven out of the top ten index heavyweights posted ...